ArticleAdvances in therapy2025

Real-World Outcomes with Orelabrutinib in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Retrospective Study.

Zi Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.